Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EcoArray was a biotechnology company specializing in environmental genomics and toxicogenomics, founded as a spin-off from the University of Florida. The company developed and commercialized microarray-based tools, specifically "EcoArrays," designed to monitor the effects of environmental contaminants on gene expression in aquatic and terrestrial wildlife. Their technology was primarily used to detect endocrine-disrupting chemicals and assess ecosystem health by analyzing molecular biomarkers. EcoArray provided specialized products and genomic services to government agencies and academic researchers before its dissolution in 2016.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EcoArray.